Dr. Eliot L. Friedman, MD

Dr. Friedman practices at Lehigh Valley Hospital-Cedar Crest in Allentown, Pennsylvania, part of Thomas Jefferson University.

Dr. Friedman's NPI, 1962453092, was assigned on May 13, 2006. Dr. Friedman graduated from University of Chicago Division of the Biological Sciences The Pritzker School of Medicine in 1981. Dr. Friedman holds Pennsylvania license MD419766.

Dr. Friedman's primary practice is Lehigh Valley Hospital-Cedar Crest, at 1200 South Cedar Crest Boulevard, Allentown, PA 18103 in Lehigh County. The practice phone is (610) 402-8000.

Dr. Friedman's primary practice is Lehigh Valley Hospital-Cedar Crest in Allentown, Pennsylvania, part of Thomas Jefferson University. Dr. Friedman is also affiliated with Lankenau Medical Center. The medical group on file is Lehigh Valley Physician Group (LVPG). Dmand AI also links Dr. Friedman to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Friedman practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Friedman's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Friedman is licensed in Pennsylvania.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, fluid and electrolyte imbalances, immune deficiency disease, lung cancer and lymphoma among the conditions Dr. Friedman treats.

CMS data shows 932 Medicare services from Dr. Friedman across 5 procedure codes in 2024, for 340 Medicare patients. Medicare paid $78,697 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 340 Medicare patients who saw Dr. Friedman in 2024. The largest group is 65 to 74, with 159 patients. 75% of them have cancer, and 75% have high blood pressure. 9% are also on Medicaid. Their average risk score is 2.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Friedman's median patient age at 71, with 60% women.

In 2024, Dr. Friedman wrote 1,114 Medicare Part D claims for 171 patients. 80% of them were for generic drugs. CMS names the drug for 856 of them, across 24 drugs with 11 or more claims each, at $1,804,235 in total drug cost. In 2023, CMS named 842 claims across 22 drugs.

Dr. Friedman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Friedman as offering telehealth.

Dmand AI links 3 papers to Dr. Friedman in 2016. Dr. Friedman's most frequent co-authors are Robert J. Kruklitis, MD, Brian John Patson, MD and Dennis Michael Sopka, MD.

CMS Open Payments shows 18 general payments to Dr. Friedman from 14 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 96% of the total. Sanofi and Genzyme US Companies paid the most, $67.

Dmand AI lists 5 awards for Dr. Friedman, most recently NCQA PCSP in 2017.

Dr. Friedman graduated from University of Chicago Division of the Biological Sciences The Pritzker School of Medicine in 1981.

Dr. Friedman is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 13. Check the plan with the practice before a visit.